News

Designed to specifically inhibit an essential mediator for bone resorption RANKL, the human monoclonal antibody is indicated for injecting subcutaneously every six months to treat osteoporosis. Pralia demonstrated

The first OTC pain reliever proven to treat Stage 2 (moderate to severe) chronic pain, Cobroxin will be marketed and distributed by Cobra. Available as an oral spray,

Kineret binds to the interleukin-1 type 1 receptor found in various tissues and organs and obstructs the biological activity of IL-1, which is a key mediator of inflammation

LAUTECH Public Relations Unit head Ayodele Adeyemo was quoted by Osun Defender as saying that the license was granted by the PCN Acting Registrar, GO Abumere and authorizes

Reinforcing its Northern Ireland’s position in the wider life sciences sector, the dual expansion represents a total investment of £13.7m with some financial assistance from Invest Northern Ireland.

The pill was earlier available to women aged 17 years and more, only on submitting their age proof at the pharmacy counters. The US Department of Justice is

Acquisition of the rights, which is still subject to certain closing conditions, will enable the firm to develop Synacthen and Synacthen Depot in the US as well as

Stating improved product’s indication, the new label provides dosing guidelines for different categories of patients, including those weighing over 100kg. The new indication states, "Acetadote is an antidote

AxION iQT system provides greater quantitative capabilities compared to a triple quad and can identify 500 compounds per second similar to a quadrupole time-of-flight (Q-TOF). The device has